FridayJan 19, 2018 12:27 pm

PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) Combining Nature and Science to Make Life Better

Company utilizing novel Caribbean blue scorpion venom therapy for immune system boost PreveCeutical seeks new ways to treat cancers, metabolic disorders, pain, infectious diseases and cardiovascular disease Partnership with University of Queensland researchers advances scientific scope of projects In the modern health care industry, disease prevention has taken a commanding role as screenings and regularly scheduled physician visits aim to minimize costs that could otherwise spiral out of control once a chronic condition is established. However, the Centers for Disease Control and Prevention report an ongoing concern that Americans are using preventive services at about half the recommended rate (…

Continue Reading

FridayJan 19, 2018 11:26 am

Proposed Merger Expands Skinvisible, Inc. (SKVI) Horizons into Multi-Billion Dollar Pain Market

Company has developed and licensed novel drug delivery systems and products for over 15 years With 14 patents, Skinvisible has proven efficacy and global reach Proposed merger may transform non-opioid pain market At the cutting edge of innovative drug delivery technology since 1999, Skinvisible, Inc. (OTCQB: SKVI), in a recently announced Letter of Intent of a proposed merger with Quoin Pharmaceuticals, is now expanding its horizons into the global pain management therapeutics market. The pain management therapeutics market is projected to expand at a 3.7 percent CAGR and exceed $83 billion in the United States by 2024 ( Skinvisible, through…

Continue Reading

WednesdayJan 17, 2018 3:04 pm

Earth Science Tech, Inc. (ETST) Caps a Year of Achievement by Doubling Revenues

Portfolio of hemp-derived CBD products Opening of new production facilities New subsidiaries, acquisitions and joint ventures Earth Science Tech, Inc. (OTC: ETST) is celebrating another year of accomplishment. In 2017, the company churned out a series of advancements that included the launch of new subsidiaries and products and an acquisition, along with entry into marketing, manufacturing and distribution agreements. It also commenced pre-launch human trials of a new product designed to join the fight against opioid addiction. As a result, 2017 revenues were almost twice as much as in 2016. Now, even though the stock is trading at around $1.00,…

Continue Reading

WednesdayJan 17, 2018 2:19 pm

Medical Cannabis Payment Solutions (REFG) Breaking the Cannabis Payment Logjam

State-sanctioned cannabis businesses forced into cash-only operations due to federal conundrum Medical Cannabis Payment Solutions has alternative for cannabis banking that solves cash handling issues Company’s proprietary system breaks logjam and provides businesses with competitive advantages As the scientific evidence of the medical efficacy of marijuana has mounted, multiple states have begun to legalize its use. Ignoring antiquated federal strictures, 29 states now permit medicinal use, with eight states allowing recreational use, and more states are expected to expand legalization this coming year. The acceptance of marijuana throughout the nation has spawned a multi-billion dollar industry, yet it has also…

Continue Reading

WednesdayJan 17, 2018 1:17 pm, Inc. (CIIX) Boosts Investor Relations Revenue, Eyes Profitability in FY2018

CIIX records sharply higher investor relations revenue in 1Q2018 and FY2017 as it expands program offerings for branding clients In FY2018, company will focus on new cryptocurrency division as it increases commitment to bitcoin education and hosts bitcoin ATM in lobby of its San Gabriel, California, headquarters Warren Wang, CEO of CIIX, sets goal of profitability in FY2018, Inc. (OTCQB: CIIX) remains diverse, but it has realigned and set a goal of profitability in FY2018 as it increases its core investor relations revenues and offerings while reaffirming its educational services in its cryptocurrency division and its commitment to bitcoin…

Continue Reading

TuesdayJan 16, 2018 2:03 pm

Earth Science Tech, Inc. (ETST) is “One to Watch”

Biotech company focused on production of cutting-edge industrial hemp, cannabis/cannabidiol (CBD) products R&D efforts include nutraceuticals, pharmaceuticals, bioceuticals, phytoceuticals and cosmeceuticals catering to health, wellness and alternative medicine markets International provisional patent application targets CBD’s powerful medicinal benefits Integration of CBD molecule with generic drug molecules opens new medical frontier U.S. consumer market for cannabinoid-based pharmaceuticals estimated at $50 billion by 2029 Medical diagnostic device MSN-2 slated for clinical tests to validate detection of various STDs Global market for diagnostic testing of STDs expected to reach $108.5 billion by 2019 Earth Science Tech, Inc. (OTC: ETST) is an innovative biotechnology…

Continue Reading

FridayJan 12, 2018 2:06 pm

SinglePoint, Inc. (SING) Facilitates Cryptocurrency Payment Solutions through SingleSeed Platform

SinglePoint capitalizing on exceptional growth in legal cannabis and cryptocurrency markets via its subsidiary, SingleSeed Bitcoin price has increased from $1,000 to over $15,000 in the last year Legal cannabis market forecast to reach more than $63 billion by 2024 A diversified holding company with operations in multiple industries and verticals, SinglePoint, Inc. (OTC: SING) is focused on providing full-service mobile technology solutions by capitalizing on two high-performing market sectors, legal cannabis and cryptocurrencies. Over the past year, the price of bitcoin has exploded, from just over $1,000 in January 2017 to over $15,000 on January 9, 2018. The legal…

Continue Reading

ThursdayJan 11, 2018 3:29 pm

Grey Cloak Tech, Inc. (GRCK) Poised with One-Stop Information and E-Commerce Solutions in Medical Cannabis Market

GRCK front-and-center in booming CBD market, which is expected to reach $2.1 billion in annual sales by 2020 The company provides current and comprehensive information via its CBD Marketplace and CBD TV channel. Learning center articles explore various topics, including the benefits of CBD oil for various conditions Grey Cloak Tech, Inc. (OTCQB: GRCK) is front-and-center in the rapidly-growing medical cannabis market and poised with one-stop information solutions and new age products and services as awareness increases regarding the potential health benefits of cannabinoids. The timing is right to position GRCK and its wholly-owned subsidiary, Eqova Life Sciences, in a…

Continue Reading

ThursdayJan 11, 2018 2:34 pm

2017 was a Transformative Year for Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP)

Lexaria’s CEO posts end of 2017 summary Multiple transformative developments – IP strengthened, broad patents awarded, finances secured Foundation for the future established – multiple opportunities on horizon If the past is any prologue, Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) should have a break out year in 2018. Lexaria’s CEO, Chris Bunka, recently posted ‘LXRP CEO’s End of 2017 Summary’. It was a transformative year with multiple accomplishments that should establish a strong foundation for the future. Lexaria Bioscience has developed, patented and commercialized a cost-effective lipophilic delivery technology, DehydraTECH™, to enhance the performance of beneficial compounds in ingestible…

Continue Reading

TuesdayJan 09, 2018 2:14 pm

Grey Cloak Tech Inc. (GRCK) Launches Online Cannabidiol Marketplace

New cannabidiol marketplace offers top-quality products and educational information Products offered through the site are carefully vetted for quality and safety CBD market estimated to reach $2.1 billion by 2021 Grey Cloak Tech Inc. (OTCQB: GRCK), a growing hemp oil products distributor (through its recently acquired wholly owned subsidiary Eqova Life Sciences), has officially launched, a premier online cannabidiol (CBD) marketplace. Grey Cloak Tech and Eqova are working to bring trust and transparency to the burgeoning CBD industry, giving consumers access to the best and latest research, innovations and products. has partnered with leading brands to offer the…

Continue Reading

Contact us: 303.498.7722